Thursday 6 December 2018

After over a decade of preclinical research and development, a new gene therapy treatment for sickle cell anemia (SCA) is reversing disease symptoms in two adults, including near elimination of chronic pain and sickling events and improved anemia.

After over a decade of preclinical research and development, a new gene therapy treatment for sickle cell anemia (SCA) is reversing disease symptoms in two adults, including near elimination of chronic pain and sickling events and improved anemia. submitted by /u/mvea
[link] [comments]


from Health https://ift.tt/2UjaPPe
via IFTTT

No comments:

Post a Comment